Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia

<p>Abstract</p> <p>We investigated the efficacy of arsenic trioxide (ATO) in patients with refractory severe aplastic anemia (SAA). A total of 5 consecutive adults were enrolled. The patients received ATO at a dose of 0.15 mg/kg intravenously daily for 5 days every week for 8 weeks...

Full description

Bibliographic Details
Main Authors: Li Ning, Song Yongping, Zhou Jian, Fang Baijun
Format: Article
Language:English
Published: BMC 2012-10-01
Series:Journal of Hematology & Oncology
Subjects:
Aplastic anemia
Hematopoiesis
Arsenic trioxide
Adipocytes
Mesenchymal stem cells
Online Access:http://www.jhoonline.org/content/5/1/61

Internet

http://www.jhoonline.org/content/5/1/61

Similar Items